deoxycytidine has been researched along with Hypertension, Malignant in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banno, S; Imai, H; Kawai, H; Miura, N; Nobata, H; Suzuki, K; Wakamatsu, R; Yamada, Y | 1 |
Caca, K; Helmchen, U; Schmidt, A; Schwella, N; von Renteln, D | 1 |
2 other study(ies) available for deoxycytidine and Hypertension, Malignant
Article | Year |
---|---|
Gemcitabine-induced hemolytic uremic syndrome mimicking scleroderma renal crisis presenting with Raynaud's phenomenon, positive antinuclear antibodies and hypertensive emergency.
Topics: Antibodies, Antinuclear; Blood Pressure; Deoxycytidine; Diagnosis, Differential; Emergencies; Female; Gallbladder Neoplasms; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension, Malignant; Immunosuppressive Agents; Kidney Glomerulus; Middle Aged; Raynaud Disease; Ribonucleotide Reductases; Scleroderma, Systemic | 2014 |
[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].
Topics: Adrenal Cortex Neoplasms; Adult; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Biopsy; Blindness; Deoxycytidine; Diagnosis, Differential; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension, Malignant; Kidney; Male; Purpura, Thrombotic Thrombocytopenic | 2008 |